Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Willmar Cancer Center at Rice Memorial Hospital
mi
from
Willmar, MN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Willmar Cancer Center at Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Missouri Baptist Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Arch Medical Services, Incorporated at Center for Cancer Care and Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Comprehensive Cancer Care, PC
mi
from
Saint Louis, MO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Comprehensive Cancer Care, PC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Immanuel Medical Center
mi
from
Omaha, NE
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Creighton University Medical Center
mi
from
Omaha, NE
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Lovelace Medical Center - Downtown
mi
from
Albuquerque, NM
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Lovelace Medical Center - Downtown
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Rutherford Hospital
mi
from
Rutherfordton, NC
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Rutherford Hospital
mi
from
Rutherfordton, NC
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - MeritCare Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Sanford Broadway Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Altru Cancer Center at Altru Hospital
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mary Rutan Hospital
mi
from
Bellefontaine, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Wood County Oncology Center
mi
from
Bowling Green, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Adena Regional Medical Center
mi
from
Chillicothe, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Adena Regional Medical Center
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
North Coast Cancer Care - Clyde
mi
from
Clyde, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
North Coast Cancer Care - Clyde
mi
from
Clyde, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Riverside Methodist Hospital Cancer Care
mi
from
Columbus, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Riverside Methodist Hospital Cancer Care
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Columbus
mi
from
Columbus, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Grant Medical Center Cancer Care
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mount Carmel West Hospital
mi
from
Columbus, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mount Carmel West Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Doctors Hospital at Ohio Health
mi
from
Columbus, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Grandview Hospital
mi
from
Dayton, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Dayton
mi
from
Dayton, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Grady Memorial Hospital
mi
from
Delaware, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Grady Memorial Hospital
mi
from
Delaware, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Community Cancer Center
mi
from
Elyria, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Community Cancer Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Hematology Oncology Center
mi
from
Elyria, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Hematology Oncology Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Wayne Hospital
mi
from
Greenville, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Fairfield Medical Center
mi
from
Lancaster, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Fairfield Medical Center
mi
from
Lancaster, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Lima Memorial Hospital
mi
from
Lima, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Lima Memorial Hospital
mi
from
Lima, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Strecker Cancer Center at Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Northwest Ohio Oncology Center
mi
from
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Luke's Hospital
mi
from
Maumee, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Luke's Hospital
mi
from
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Knox Community Hospital
mi
from
Mount Vernon, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Knox Community Hospital
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Licking Memorial Cancer Care Program at Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Fisher-Titus Medical Center
mi
from
Norwalk, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Fisher-Titus Medical Center
mi
from
Norwalk, OH
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Charles Mercy Hospital
mi
from
Oregon, OH
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Charles Mercy Hospital
mi
from
Oregon, OH
Click here to add this to my saved trials